Emerging Role and Place of Probiotics in the Management of Pediatric Neurodevelopmental Disorders

Himani Narula Khanna; Sushovan Roy; Aqsa Shaikh; Viswanath Bandi

doi:10.5005/jp-journals-10018-1384

Emerging Role and Place of Probiotics in the Management of Pediatric Neurodevelopmental Disorders

Euroasian J Hepatogastroenterol. 2022 Jul-Dec;12(2):102-108. doi: 10.5005/jp-journals-10018-1384.

Authors

Himani Narula Khanna¹, Sushovan Roy², Aqsa Shaikh², Viswanath Bandi³

Affiliations

¹ Department of community Medicine, HIMSR, Jamia-Hamdard University, New Delhi, India.
² Department of Community Medicine, HIMSR, New Delhi, India.
³ Research Scholar, Faculty of management studies, ICFAI University, Ranchi, Jharkhand, India.

Abstract

The current decade has witnessed significant developments with the latest therapeutic agents for managing various infectious diseases to complex hemato-oncological conditions, leading to a decrease in morbidity and mortality, while improving the quality of life (QoL), and increasing the life span. Non-communicable diseases (NCDs), which are on the rise across all age-groups, are being driven by unhealthy lifestyles and improved mental health issues. The current therapeutic agents were found to offer only symptomatic relief of varying efficacy and significant adverse effects, leading clinicians to evaluate other options for the management of both neurodevelopmental and neurodegenerative disorders. The role of gut microbiota has emerged as a potential target for the treatment of both neurodegenerative diseases and neurodevelopmental disorders like attention-deficit hyperactivity disorder (ADHD)/autism spectrum disorders (ASD) as a result of the decoding of the human genome and advances in our understanding of the human gut microbiome, including its interactions with the human brain. This review has been undertaken to understand on date level of understanding of human microbiota and towards identifying probiotic strains with proven efficacy and safety. According to recent investigations, several lactobacillus strains, including L. Paracasei 37, L. Planetarium 128, L. reuteri DSM 17938, and Bifidobacterium longum, have been effective in treating children's neurodevelopmental disorders such as ASD and ADHD. Future clinical studies are nonetheless required to confirm the long-term safety and effectiveness of probiotic strains in managing the primary and comorbid symptoms, hence improving patient and family quality of life.

How to cite this article: Khanna HN, Roy S, Shaikh A, et al. Emerging Role and Place of Probiotics in the Management of Pediatric Neurodevelopmental Disorders. Euroasian J Hepato-Gastroenterol 2022;12(2):102-108.

Keywords: Dysbiosis; Gut-brain axis; Neurodevelopmental disorders; Psychobiotics.

Publication types

Review